NTRK IHC
This test detects NTRK gene fusions, which are associated with various cancers, including sarcomas and cancers of the thyroid, lung, and brain. It aids in targeted therapy selection.
NTRK IHC Test in Bengaluru Overview
No special preparations needed
- Case No.
- Specimen Type
- Clinical Details
- Gross Appearance
- Microscopy
- Impression
- Reference
- Comment
- Note
- Addendum
The NTRK IHC test detects the expression of neurotrophic tyrosine receptor kinase (NTRK) proteins in tumors using immunohistochemistry (IHC). NTRK gene fusions are associated with certain cancers.
This test is recommended for:
- Patients with advanced or metastatic solid tumors.
- Individuals with tumors that are unresponsive to standard therapies.
A tissue biopsy is collected, and IHC staining is used to assess the presence of NTRK protein expression.
- Positive Result: Suggests the presence of NTRK gene fusion, indicating eligibility for targeted therapies.
- Negative Result: Suggests no detectable NTRK protein expression.
NTRK-positive tumors may respond to targeted therapies such as TRK inhibitors, improving treatment outcomes.
Test code
307AR00
Specimen vol. and vacutainer information
| Specimen | Vacutainer | Volume |
|---|---|---|
| Paraffin Block | Others | |
| Slides | Slider Mail Box |
Specimen stability information
Paraffin Block, Slides
Specimen rejection criteria
Test run frequency
Every Day TIME - 18:30
Turn around time
3 Working Days
Performing locations
Department
- Coe -histopath
CPT and Loinc codes
Package price
₹3600
Need Help?
Talk to our health experts for guidance on tests, reports, or bookings.
WhatsApp to Book TestNTRK IHC
₹3600